/PRNewswire/ Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Investigational New Drug (IND) clearance from the.
STOCKHOLM, Dec. 2, 2021 /PRNewswire/ Sedana Medical AB (publ) (SEDANA: FN Stockholm) ("Sedana Medical" or "Company") hereby announces the Company's intention to, by exercise of the authorisation
/PRNewswire/ Sedana Medical AB (publ) (SEDANA: FN Stockholm) ("Sedana Medical" or "Company") hereby announces the Company s intention to, by exercise of the.
/PRNewswire/ Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has submitted an Investigational New Drug (IND) application to.